Leucemia linfocítica crónica

Solicite una Consulta

Stages

Estadificación

Una vez que se confirma un diagnóstico, el médico usa la información sobre tu cáncer para determinar el estadio de tu leucemia linfocítica crónica. El estadio le indica al médico cuál es la agresividad del cáncer y cuáles son las probabilidades de que empeore rápidamente.

Los estadios de la leucemia linfocítica crónica pueden usar letras o números. En general, los estadios más tempranos de la enfermedad no necesitan tratamiento de inmediato. Las personas con cáncer en las etapas finales pueden considerar comenzar un tratamiento de inmediato.

Solicite una consulta
Diagnóstico y tratamiento
April 30, 2025

Living with leucemia linfocítica crónica?

Connect with others like you for support and answers to your questions in the Blood Cancers & Disorders support group on Mayo Clinic Connect, a patient community.

Blood Cancers & Disorders Discussions

atir
Polycythemia Vera: Just been diagnosed

431 Replies Thu, Nov 13, 2025

anavleek
Essential thrombocythemia (ET): When to start hydroxyurea (HU)?

110 Replies Thu, Nov 13, 2025

sandramgus
Diagnosed: MGUS

139 Replies Thu, Nov 13, 2025

See more discussions
  1. Niederhuber JE, et al., eds. Chronic lymphocytic leukemia. In: Abeloff's Clinical Oncology. 6th ed. Elsevier; 2020. https://www.clinicalkey.com. Accessed April 13, 2021.
  2. Kaushansky K, et al., eds. Chronic lymphocytic leukemia. In: Williams Hematology. 10th ed. McGraw Hill; 2021. https://accessmedicine.mhmedical.com. Accessed April 13, 2021.
  3. AskMayoExpert. Chronic lymphocytic leukemia (CLL) (adult). Mayo Clinic; 2019.
  4. Chronic lymphocytic leukemia/small lymphocytic leukemia. National Comprehensive Cancer Network. https://www.nccn.org/guidelines/guidelines-detail?category=1&id=1478. Accessed April 13, 2021.
  5. Chronic lymphocytic leukemia treatment (PDQ) — Patient version. National Cancer Institute. https://www.cancer.gov/types/leukemia/patient/cll-treatment-pdq. Accessed April 13, 2021.
  6. Cancer-related fatigue. National Comprehensive Cancer Network. https://www.nccn.org/guidelines/guidelines-detail?category=3&id=1424. Accessed April 13, 2021.
  7. Warner KJ. Allscripts EPSi. Mayo Clinic. Feb. 8, 2021.
  8. Shanafelt TD, et al. Hematologist/oncologist disease-specific expertise and survival: Lessons from chronic lymphocytic leukemia (CLL)/small lymphocytic leukemia (SLL). Cancer. 2012; doi:10.1002/cncr.26474.
  9. Ding W, et al. Pembrolizumab in patients with CLL and Richter transformation or with relapsed CLL. Blood. 2017; doi:10.1182/blood-2017-02-765685.
  10. Archibald WJ, et al. Atrial fibrillation in patients with chronic lymphocytic leukemia (CLL) treated with ibrutinib: Risk prediction, management and clinical outcomes. Annals of Hematology. 2021; doi:10.1007/s00277-020-04094-3.
  11. Lymphoma SPOREs. National Cancer Institute. https://trp.cancer.gov/spores/lymphoma.htm. Accessed April 23, 2021.
  12. Sites. Chronic lymphocytic leukemia Research Consortium (CRC). https://cll.ucsd.edu/research-sites. Accessed April 23, 2021.
  13. Slager SL, et al. Natural history of monoclonal B-cell lymphocytosis among relatives in CLL families. Blood. 2021; doi:10.1182/blood.2020006322.

Leucemia linfocítica crónica